[Burkitt lymphoma: Definition, diagnostic approach, and current therapeutic strategies].
A clinical review synthesizes current evidence on Burkitt lymphoma diagnosis and treatment for a rare but curable aggressive blood cancer.
This narrative review provides a structured clinical overview of Burkitt lymphoma, a rare and highly aggressive B-cell neoplasm, aligned with the 2022 WHO classification and covering diagnostic workup and therapeutic strategies including high-intensity immunochemotherapy. While not presenting original data, the review offers a useful clinical reference for an uncommon hematologic malignancy.
What the study was
- Study design
- Narrative review
- Population
- All ages with Burkitt lymphoma; reflects 2022 WHO classification update
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Bulletin du cancer
Why it surfaced
Current clinical review of Burkitt lymphoma aligned with updated WHO classification; relevant reference for clinicians managing this rare aggressive lymphoma.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.